Axsome Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.About AXSM
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview.
AXSM Key Statistics
Stock Snapshot
Axsome Therapeutics(AXSM) stock is priced at $213.68, giving the company a market capitalization of 11.38B. It carries a P/E multiple of -56.84.
On 2026-08-14, Axsome Therapeutics(AXSM) stock traded between a low of $212.68 and a high of $221.55. Shares are currently priced at $213.68, which is +0.5% above the low and -3.6% below the high.
The Axsome Therapeutics(AXSM)'s current trading volume is 705.29K, compared to an average daily volume of 848.46K.
In the last year, Axsome Therapeutics(AXSM) shares hit a 52-week high of $260.19 and a 52-week low of $107.81.
In the last year, Axsome Therapeutics(AXSM) shares hit a 52-week high of $260.19 and a 52-week low of $107.81.
AXSM News
...
Axsome Therapeutics, Inc. recently reported second-quarter 2026 results, with revenue rising to US$218.38 million from US$150.04 million a year earlier, while n...
Reports Q2 revenue $218.38M, consensus $221.78M. “The second quarter was highly productive for Axsome. Our commercial business grew robustly, driven by strong u...
Analyst ratings
91%
of 23 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.